Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Inflammatory Bowel Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04577794
What this trial is testing

A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Lakefront Biotherapeutics NV 31
Large-scale testing (Phase 3)Looking for participantsNCT05995353
What this trial is testing

Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
AbbVie 110
Testing effectiveness (Phase 2)Looking for participantsNCT07186101
What this trial is testing

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

Who this might be right for
Ulcerative Colitis
Eli Lilly and Company 252
Large-scale testing (Phase 3)Study completedNCT01277666
What this trial is testing

Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
GlaxoSmithKline 608
Testing effectiveness (Phase 2)Study completedNCT04613518
What this trial is testing

The Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants With Moderate to Severe Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Bristol-Myers Squibb 38
Large-scale testing (Phase 3)Study completedNCT03945188
What this trial is testing

Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Arena Pharmaceuticals 433
Testing effectiveness (Phase 2)Study completedNCT04996797
What this trial is testing

Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005)

Who this might be right for
Ulcerative Colitis
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 178
Testing effectiveness (Phase 2)UnknownNCT03609905
What this trial is testing

Adipose Mesenchymal Stem Cells (AMSC) for Treatment of Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Liaocheng People's Hospital 50
Large-scale testing (Phase 3)Study completedNCT00032799
What this trial is testing

Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease

Who this might be right for
Crohn's Disease
Biogen 905
Not applicableLooking for participantsNCT06095596
What this trial is testing

Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Sixth Affiliated Hospital, Sun Yat-sen University 334
Not applicableActive Not RecruitingNCT05841537
What this trial is testing

An Observational Study to Assess Change in Disease Activity and Adverse Events In Adult Participants With Moderate to Severe Active Crohn's Disease (CD)

Who this might be right for
Crohn's Disease
AbbVie 1,019
Not applicableStudy completedNCT04799496
What this trial is testing

Kynteles Injection (Vedolizumab) in Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease or Chronic Pouchitis

Who this might be right for
Inflammatory Bowel DiseasesColitis, UlcerativeCrohn Disease
Takeda 688
Testing effectiveness (Phase 2)Looking for participantsNCT07513181
What this trial is testing

Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative ColitisInflammatory Bowel DiseasesAutoimmune Diseases
Athos Therapeutics Inc 120
Not applicableLooking for participantsNCT07385131
What this trial is testing

Prophylactic Dexamethasone Before Infliximab in Moderate-to-Severe IBD

Who this might be right for
Inflammatory Bowel Disease (IBD)CD - Crohn's DiseaseUC - Ulcerative Colitis
Second Affiliated Hospital, Zhejiang University, School of Medicine 300
Post-approval studies (Phase 4)Study completedNCT02318667
What this trial is testing

Correlation of Soluble Suppression of Tumorigenicity 2 (ST2) With Golimumab (MK-8259) Response in Participants With Ulcerative Colitis (UC) (MK-8529-022).

Who this might be right for
Colitis, Ulcerative
Merck Sharp & Dohme LLC 38
Testing effectiveness (Phase 2)Looking for participantsNCT07374471
What this trial is testing

MB-001 in Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Mage Biologics 100
Not applicableLooking for participantsNCT05987852
What this trial is testing

Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)

Who this might be right for
Ulcerative Colitis
Northwestern University 126
Not applicableLooking for participantsNCT06764706
What this trial is testing

Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AbbVie 200
Large-scale testing (Phase 3)Looking for participantsNCT07184944
What this trial is testing

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Sanofi 751
Not applicableStudy completedNCT01218360
What this trial is testing

Observational Study of Disease Severity in Participants Diagnosed With Crohn's Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn's Disease (Protocol P06484)

Who this might be right for
Crohn Disease
Merck Sharp & Dohme LLC 71
Next Page